Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free ...

STONY BROOK, NY / ACCESSWIRE / / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion of the buildout of ...

The Company also announced that it is actively negotiating a supply agreement for GMP IVT template with a mRNA therapeutic developer. Separately, the Company reaffirmed its intention to complete ...